- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for gBRCA1/2 Operable TNBC, Neoadjuvant Trastuzumab & Pertuzumab +/- Paclitaxel for HER2+/HR− EBC
68 views
July 22, 2021
Comments 0
Login to view comments.
Click here to Login
2021 Virtual KU Hematology and Medical Oncology Review